News Hub | News Direct

Technology

Artificial Intelligence Big Data Cloud Computing Cyber Security Data Management Electronics Enterprise & Network Technology Financial Technology Hardware Mobile & Wireless Nanotechnology Semiconductor Software Telecommunications
Article thumbnail News Release

Cepton announces record LiDAR shipments as company unveils 2Q earnings

Cepton Inc

Cepton Inc. vice president of Product Brunno Moretti joined Steve Darling from Proactive to discuss the company's second-quarter performance and strategic developments. Cepton has achieved a new company record for shipments of LiDAR technology across the automotive and smart infrastructure markets, showcasing the company's strong momentum. Moretti highlighted that Cepton is anticipating a significant increase in shipment volume for each subsequent quarter throughout the remainder of the year. The company is also actively fulfilling a multi-million dollar tolling contract, a significant achievement within its portfolio. In addition, Moretti mentioned the company's strategic expansion, particularly in Detroit, where Cepton has bolstered its team with industry expert Luis Gonçalves, formerly associated with General Motors (GM) and the American automotive sector. This move is expected to support Cepton's volume production operations and enhance its market presence. Cepton's strong 2Q performance, strategic partnerships, and expansion efforts underscore its commitment to advancing lidar technology and its applications in the automotive and smart infrastructure sectors. Contact Details Proactive Investors +1 604-688-8158 na-editorial@proactiveinvestors.com

August 17, 2023 12:56 PM Eastern Daylight Time

Video
Article thumbnail News Release

Spectral MD takes steps toward Rosecliff Acquisition Corp merger

Spectral MD Holdings Ltd

Spectral MD Holdings' general counsel Vince Capone joins Steve Darling on Proactive to provide insights into the latest developments at the company. Capone highlighted the significance of Rosecliff Acquisition Corp's filing of Form 424, a crucial step in Spectral MD's ongoing journey. This filing is triggered by the effectiveness of the RS-4 with Rosecliff, signifying an upcoming shareholder meeting to approve the transaction. The merger aims to reshape Spectral MD into a holding company under Rosecliff, adopting the new name "Spectral AI." This transformation also involves a NASDAQ ticker change from "CLF" to "MD AI." Capone underlined a significant milestone – the successful clearance of the SEC examiner's review, which is pivotal for the transaction. He noted the accelerated timeline for this process compared to the typical three to four months, indicating the company's agile approach. The timeline for further progress is set for September 8, targeting the NASDAQ listing, and the company's exit from other markets. With shareholder meetings for both Spectral MD and Rosecliff scheduled for August 31 and September 6 respectively, the rapid pace of developments is evident. Capone expressed his enthusiasm for the exciting journey ahead, recognizing the dedicated efforts of the team. The transformation promises to be a substantial stride for Spectral MD, and the interview concluded with anticipations for the upcoming listing and more updates. Contact Details Proactive USA +1 604-688-8158 na-editorial@proactiveinvestors.com

August 17, 2023 12:51 PM Eastern Daylight Time

Video
Article thumbnail News Release

Gamelancer Media beats its own forecasts with 2Q financial results

Gamelancer Media Corp

Gamelancer Media Corp CEO Jon Dwyer joined Steve Darling from Proactive to announce the company's financial achievements for the second quarter of 2023. The reported results surpassed management's expectations, showcasing an impressive 171% growth in revenue to C$1.42 million for the quarter ended June 30, 2023, compared to the same period in 2022. Dwyer emphasized to Proactive that the 2Q 2023 financial report not only highlights Gamelancer's exceptional revenue growth but also underscores the company's capacity to foster sustainable growth both in terms of revenue and network expansion. He emphasized that Gamelancer's unique value proposition, which combines owned and operated channels with its creative studio JoyBox, sets the stage for a distinctive media offering to brands. Dwyer also shared the company's ongoing efforts to optimize operational costs, a strategy that aligns with its goal of achieving positive underlying earnings (EBITDA) results by the fourth quarter of 2023. This commitment to financial efficiency and strategic growth positions Gamelancer for continued success in the competitive media landscape. Contact Details Proactive Investors Canada +1 604-688-8158 na-editorial@proactiveinvestors.com

August 17, 2023 12:44 PM Eastern Daylight Time

Video
Article thumbnail Digital Asset Direct

Family Tech for School and Home

News Media Group, Inc.

Contact Details News Media Group, Inc. Karl Wayne +1 334-440-6397 karl@newsmg.com Company Website https://newsmg.com/

August 17, 2023 12:01 PM Eastern Daylight Time

Video
Article thumbnail News Release

Harvest Thermal Earns Inclusion in CEC Title 24 Compliance Software

Harvest Thermal

The electronic rulebook of Title 24 compliance for energy now includes Harvest Thermal’s smart thermal battery solution as an efficiency option. The California energy code for new construction and major remodels is becoming increasingly challenging to meet. Architects, homebuilders and remodelers need more cost-effective solutions to include in their projects. Harvest Thermal offers project developers a climate-friendly and cost-effective tool to meet code requirements. Its unique thermal battery solution uses a single heat pump for both heating and hot water. The smart Harvest Pod leverages cheap, clean electricity to store heat at midday while releasing it to the home whenever needed. Smart controls optimize for homeowner comfort while delivering up to 45% lower energy costs and 90% carbon reductions compared to gas. “Harvest Thermal’s inclusion in the CEC Title 24 database is very significant for architects, homebuilders and remodelers,” said Pierre Delforge, Head of Product and Operations at Harvest Thermal. “They will see outsized benefits with significantly lower EDR scores, lowering their costs and improving the performance of their buildings.” Building plans submitted for permitting must achieve scores at or below the Energy Design Rating (EDR) compliance threshold as calculated by the CBECC-Res compliance software. Plans that include Harvest Thermal get extra credit, lowering both Efficiency and Total EDR scores, and helping to avoid other more costly measures. Harvest Thermal also qualifies for the new California Electric Homes Program (CalEHP) for all-electric new construction, bringing more value to homebuilders’ projects. The technology fits into recognizable floorplans, enabling developers to seamlessly integrate Harvest into their designs. For more information on how to incorporate Harvest Thermal into the CBECC-Res database as a combined heat and hot water system see the instructions in this presentation. Harvest Thermal is redesigning home heating, cooling and hot water for the planet. Its market-leading thermal battery system cuts carbon emissions by 90% from home heating and hot water compared to gas and 50% compared to heat pumps without storage. The cloud-connected Harvest Pod leverages machine learning software, sensors, and controls to reduce carbon emissions and save on monthly heating bills. It also supports a cleaner, cheaper, and more resilient grid. Founded in 2019, Harvest Thermal has received support from the National Science Foundation, the California Energy Commission, Peninsula Clean Energy, and leading private investors. In 2023, Harvest Thermal was named to Fast Company’s Most Innovative Companies list; awarded NREL Industry Growth Forum’s People’s Choice Award; and won a Silver Edison Award for Sustainable Design in the category of Consumer Solutions. Contact Details Harvest Thermal David Tuft +1 202-494-0813 david@harvest-thermal.com Company Website https://www.harvest-thermal.com/

August 17, 2023 08:00 AM Pacific Daylight Time

Image
Article thumbnail News Release

Portfolio Trading Insights on H1 2023: Volumes and Execution Quality Take Center Stage

Tradeweb

The first half of 2023 offered a volatile macro backdrop for U.S. credit markets, as elevated inflation, rates uncertainty and an ongoing banking crisis continued to weigh on our markets. Despite these hurdles, one constant theme in credit markets has been the use of portfolio trading to move large baskets of risk. Tradeweb has been the market leader in electronifying this protocol and our growth has continued through 2023, with combined U.S. Investment Grade (IG) and U.S. High Yield (HY) volumes in portfolio trading up 22% in the first half of 2023 compared with prior year period. This momentum continued into July; we estimate portfolio trading made up 6% [1] share of total TRACE in July 2023, which is the highest we’ve seen since November 2021. In this piece we highlight some of the trends we’ve seen in portfolio trading over the first six months of 2023 – and what this could mean for the next wave of portfolio trading innovation. For example, in response to growing client engagement and interest in using the protocol in different ways, we recently introduced ‘Bulk Crossing’ functionality within portfolio trading to allow clients and dealers to trade more efficiently by trading hundreds (or thousands) of corporate bonds with Treasury hedges, while consolidating the numerous Treasury trades into one ticket per benchmark. This feature allows both clients and dealers to trade more efficiently by reducing their number of tickets, and has grown in popularity for both Net Proceeds and Trade-at-Close (or Ref+) portfolio trades. Measuring the Size of the U.S. Portfolio Trading Market – An Update On May 15, 2023, the FINRA TRACE reporting rules took effect which require dealers to start reporting their portfolio trade transactions to TRACE. This change signifies how far portfolio trading has come over the past five years; it is a testament to the increased electronification of this protocol and of credit markets more broadly. The new requirements allow market participants to achieve a better understanding of the size of the market and therefore adjust their pricing models to consume these trades in a more informed way. This new reporting metric has also allowed us to validate our model for estimating portfolio trading market size on TRACE (discussed in more detail here ). We will continue to monitor the performance of our portfolio trading estimation model as more portfolio trades are tagged on TRACE over the coming months. [1] Based on TRACE Portfolio Trading Execution Volumes Vary Throughout the Month Portfolio trading is utilized by clients for a multitude of reasons. This can range from very specific sector level views to huge monthly or quarterly rebalances. Month-end tends to be a popular time for portfolio trades for a variety of reasons. Below we illustrate the average day’s volume given its position in the month during the first half of 2023 vs the first half of 2022. Looking at the chart below, the final week of the month averaged 42% more volume as compared to the previous weeks during the month. This trend helped drive the overall increase in portfolio trading over the last year. One reason that month-end is a popular time for portfolio trades is that the protocol provides an easy way for clients to rebalance their portfolio to maintain their monthly mandates and exposures. These types of rebalancing trades are typically slightly larger in size and have more line items than other portfolio trades. We can see this activity in the data: in H1 2023, portfolio trade baskets traded on Tradeweb during the last three days of the month averaged 17% more volume and 47% more line items as compared to portfolios traded during the previous days of the month. Portfolio trades near month-end also tend to include more distinct sectors in their make up as compared to portfolio trades happening at other times of the month. Although this is not a direct measure of diversity in bond portfolios, this larger sector range is also indicative of these rebalancing type trades. Portfolio Trading Execution Quality As discussed in earlier blog posts, there are several ways of measuring execution quality for trading in credit markets. One metric we use in our transaction cost analyses is the percentage bid/offer spread captured (%BOS). This is simply the percentage of Tradeweb Ai-Price bid/offer spread that the traded level captured. In H1 2023, we saw improvements in portfolio trade execution quality compared to H1 2022. The median %BOS captured is now very close to mid and has almost returned back to 2021 levels. HY portfolio trade execution quality has also significantly improved since the beginning of the year, despite HY TRACE having fallen around 4% from H1 2022 to H1 2023. We also previously discussed the factors that drive portfolio execution quality at the portfolio level. One interesting trend we wanted to explore further was execution quality at the line level in a portfolio trade and how it varies by size. Intuitively, we would expect higher execution costs on chunkier lines in the portfolio due to a size premium, but also potentially higher costs on those with very small size. This is because a client may be willing to incur slightly higher costs on small trades in order to obtain the certainty of execution on these items. Using H1 2023 Tradeweb portfolio trading data, we looked at how the %BOS captured varied by line size. We can clearly see both in IG and HY that execution quality falls as line size increases, which is expected due to the extra cost associated with trading large sizes. The chart also implies that the optimal size for execution quality is around 50k-500k for IG and 50k-100k in HY, which corresponds with what we tend to see on average for portfolio trades on our platform. The inverted U shape is also indicative of the ‘small trade’ effect where trade costs may be slightly higher for very small line sizes. This implies that clients are willing to accept comparatively worse levels on those bonds since they know they are able to trade them with certainty as part of the broader basket. This effect, however, seems to be much smaller than the higher costs associated with larger line sizes and is still well inside the bid/offer. Looking Forward Even as TRACE volumes declined in Q2 2023 as compared with strong comps in Q1 2023, we’ve seen portfolio trading continue to maintain its significant share of the overall market, and we believe it is here to stay. As the protocol evolves, such as we have seen with the use of Bulk Crossing, we are confident that clients will continue to leverage portfolio trading in innovative ways, and in every market condition. About Tradeweb Markets Tradeweb Markets Inc. (Nasdaq: TW) is a leading, global operator of electronic marketplaces for rates, credit, equities and money markets. Founded in 1996, Tradeweb provides access to markets, data and analytics, electronic trading, straight-through-processing and reporting for more than 40 products to clients in the institutional, wholesale and retail markets. Advanced technologies developed by Tradeweb enhance price discovery, order execution and trade workflows while allowing for greater scale and helping to reduce risks in client trading operations. Tradeweb serves approximately 2,500 clients in more than 65 countries. On average, Tradeweb facilitated more than $1.2 trillion in notional value traded per day over the past four quarters. For more information, please go to www.tradeweb.com. Forward-Looking Statements This release contains forward-looking statements within the meaning of the federal securities laws. Statements related to, among other things, our outlook and future performance, the industry and markets in which we operate, our expectations, beliefs, plans, strategies, objectives, prospects and assumptions and future events are forward-looking statements. We have based these forward-looking statements on our current expectations, assumptions, estimates and projections. While we believe these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond our control. These and other important factors, including those discussed under the heading “Risk Factors” in documents of Tradeweb Markets Inc. on file with or furnished to the SEC, may cause our actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements contained in this release are not guarantees of future performance and our actual results of operations, financial condition or liquidity, and the development of the industry and markets in which we operate, may differ materially from the forward-looking statements contained in this release. In addition, even if our results of operations, financial condition or liquidity, and events in the industry and markets in which we operate, are consistent with the forward-looking statements contained in this release, they may not be predictive of results or developments in future periods. Any forward-looking statement that we make in this release speaks only as of the date of such statement. Except as required by law, we do not undertake any obligation to update or revise, or to publicly announce any update or revision to, any of the forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this release. Contact Details Tradeweb Media Contact Daniel Noonan +1 646-767-4677 Daniel.Noonan@Tradeweb.com Company Website http://www.tradeweb.com

August 17, 2023 10:47 AM Eastern Daylight Time

Image
Article thumbnail News Release

PathAI Announces Commercial Availability of AISight™ Digital Pathology Image Management System to Power the Next Generation of Pathology Labs

PathAI

PathAI, a global leader in AI-powered pathology, today announced the commercial launch of its AISight TM digital pathology image management system (IMS) for anatomic pathology laboratories. 1 The launch comes at a time when the pathology space is increasingly transitioning to digitally-enabled reads and recognizing the utility of AI and machine learning to enhance quality control, standardize diagnoses, and quantitate biomarkers. AISight is a cloud-based platform that enables efficient, end-to-end digital pathology workflows. AISight provides best-in-class image and case management, ingestion, and viewing while seamlessly enabling access and deployment of AI applications. AISight can also be integrated bidirectionally with laboratory information systems for streamlined workflow adoption. Anatomic pathology laboratories of all sizes and specialties – including health systems, reference laboratories, independent pathology labs, and academic medical centers – may utilize AISight. 1 “We are thrilled to make the AISight Image Management System available to labs globally. We’ve been honing this platform with input from hundreds of pathologists from dozens of institutions, and this launch underpins all of the work PathAI does to support pathologists, biopharma partners, and the academic research community,” said Dr. Andy Beck, M.D. Ph.D., chief executive officer and co-founder of PathAI. “Expanding the feature set to support pathology workflows as an IMS for anatomic pathologist laboratories is a natural progression for PathAI as we strive to meet our mission of improving patient outcomes with AI-powered pathology.” This announcement builds on prior progress as PathAI’s solutions increasingly support digital pathology workflows. In March of this year, PathAI announced the Early Access Program for AISight, and the 12 leading anatomic pathology laboratories that began trialing the platform. Subsequently, PathAI announced the availability of its first 5 algorithm products through the platform including AIM-PD-L1 algorithms across 4 indications, and the AIM-HER2 Breast Cancer algorithm. 2 In addition to AISight for research use, PathAI also has a regulated platform, AISight™ Dx, that has 510(k) clearance for primary digital diagnosis in the US and is CE-marked in the EU. “We have been overwhelmed with the positive feedback from pathologists, lab directors, operators, and administrators who have trialed AISight and we’re excited to make it available at scale,” said Eric Walk, M.D., F.C.A.P., chief medical officer at PathAI. “AISight provides a one-stop shop for digital pathology case management that is flexible for multiple use cases given its interoperability and configurability. We will continue iterating on new and improved features as we listen to our users and release updates as they become available.” To learn more about AISight IMS, register for our upcoming webinar, visit our website, or meet with our team at upcoming conferences including ECP, CAP, and PathVisions. 1 AISight™ is for research use only. Not for clinical use in diagnostic procedures. 2 AIM-PD-L1™ and AIM-HER2™are research use only. Not for clinical use in diagnostic procedures. About PathAI PathAI is the only AI-focused technology company to provide comprehensive precision pathology solutions from wet lab services to algorithm deployment for clinical trials and diagnostic use. Rigorously trained and validated with data from more than 15 million annotations, its AI-powered models can be leveraged to optimize the analysis of patient samples to improve efficiency and accuracy of pathology interpretation, as well as to better gauge therapeutic efficacy and accelerate drug development for complex diseases. PathAI, which is headquartered in Boston, MA, and operates a CAP/CLIA-certified laboratory in Memphis, TN, is proud to have a team of 600+ innovative thinkers from around the globe. For more information, please visit www.pathai.com. Contact Details SVM Public Relations and Marketing Communications Maggie Naples +1 401-490-9700 pathai@svmpr.com Company Website https://www.pathai.com/

August 17, 2023 10:00 AM Eastern Daylight Time

Article thumbnail News Release

Agora Data Successfully Secures $160 Million in Fourth Private Term Financing

Agora Data, Inc.

Agora Data, Inc., a fintech company transforming automotive financing for U.S. car dealerships by offering abundant, low-cost capital with precision loan performance data and analytics, closed a $160 million private term financing on August 11, 2023. This latest transaction represents the fourth privately placed term financing for Agora. Each of the company’s first three term financings performed better than projected. “To close a term financing transaction in today’s challenging market conditions is proof-positive of the strength of the Agora team and how accurately we manage and predict portfolio performance,” said Steve Burke, CEO, Agora Data. “Fueling Agora’s mission to enable any car dealer to be a finance company, this $160 million private term financing provides additional funding capacity and reiterates our commitment to our customers’ future growth.” The $160 million private term financing marks a significant milestone in Agora Data’s growth trajectory. The company closed the first-ever crowdsourced auto securitization in late 2020, introducing a new way for car dealerships to access capital markets financing by aggregating loan portfolios of varying sizes. The company’s diversified financing strategy has resulted in multiple successful crowdsourced securitizations and private term transactions, all powered by its proprietary artificial intelligence (AI) and machine learning algorithms. With its patent pending modeling that delivers unparalleled accuracy, Agora leverages over $350 billion of loan data for car dealerships to optimize their non-prime portfolios. As a result, more favorable financing terms and highly competitive loan interest rates are available, reshaping the landscape of lending possibilities for dealers and finance companies to finance more non-prime customers, sell more cars, and make more money. Access to abundant capital has been a longstanding challenge for U.S. car dealers who offer or who want to offer financing to non-prime customers. Agora proactively addresses these challenges and presents a transformative fintech approach for dealers to keep their customers and make a gross profit on cars and financing profit on loans. # # # About Agora Data, Inc. Agora Data, Inc. is an automotive industry fintech revolutionizing financing for car dealers and finance companies. Car dealerships can secure affordable capital to build their own non-prime captive finance company, obtain actionable loan performance data to improve their lending portfolios, and use a wide range of solutions to grow their business safely. Powered by patent pending artificial intelligence (AI) and machine learning technology, car dealers can access real-time data analytics and planning resources to help optimize the performance of their portfolios. Agora Data made history by closing the first-ever crowdsourced non-prime auto securitization in 2020 and continually brings groundbreaking financing solutions to an underserved market. For more information, visit www.agoradata.com or contact us at 1-877-592-4672. Contact Details Eric Nemeth nemeth@ericpr.com Company Website https://agoradata.com/

August 17, 2023 09:06 AM Eastern Daylight Time

Article thumbnail News Release

Quantum Silicon Production Project awarded $5.1m funding under the Defence Trailblazer Program

Silex Systems Limited

August 17, 2023 (AEST): Silex Systems Limited (Silex) (ASX: SLX) (OTCQX: SILXY) is pleased to announce the award of $5.1m in funding from the Defence Trailblazer for Concept to Sovereign Capability Program, a strategic partnership between The University of Adelaide and UNSW Sydney (UNSW), supported by the Australian Government Department of Education through the Trailblazer Universities Program. The funding will support the establishment of a Quantum Silicon Production Plant, which aims to deliver an end-to-end manufacturing facility at the Company’s Lucas Heights technology centre. It is anticipated that the first production module will produce between 5kg to 10kg annually of ZS-Si (in the form of halo-silane), which will then be converted to multiple Q-Si product forms for potential customers in the global silicon-based quantum computing industry. The new project will be undertaken in conjunction with partners, Silicon Quantum Computing Pty Ltd (SQC) and UNSW, and follows on from an earlier project that demonstrated efficient production of gram quantities of ZS-Si, with enrichment of silicon-28 up to ~99.998% purity. Michael Goldsworthy, Silex’s CEO/Managing Director, said: “We are delighted to receive funding under the Federal Government’s Defence Trailblazer Program, which will assist us to transition our Zero-Spin Silicon enrichment technology from the pilot demonstration level to commercial-scale, including the development of product conversion technology to produce two forms of commercial Quantum Silicon products (gas and solid) required by emerging silicon quantum chip fabricators around the world.” “This enables us to capitalise on the results achieved in the recently completed Zero-Spin Silicon Project for our innovative SILEX laser isotope separation technology, and to establish a sovereign capability and secure supply chain for this critical enabling material for the emerging silicon quantum computing industry. Previously, the main supply of enriched silicon came from Russia, but this source has been disrupted by geopolitical events”, he added. Professor Michelle Simmons AO, CEO of SQC, said: “Following the successful collaboration under the CRC-P program, SQC is tremendously excited about the expansion of our partnership with Silex through the Trailblazer Quantum Silicon Production Project. The Trailblazer funding supports Silex’s commercial-scale production of Quantum Silicon, the key enriched silicon material essential to the manufacture of SQC’s atom-scale quantum computers in Australia. The creation of a sovereign supply of this vital material comes at a time when our traditional source of supply has been disrupted. We couldn’t be more motivated to support this Project.” Dr Sanjay Mazumdar, Executive Director, Defence Trailblazer, said: “The Defence Trailblazer looks forward to supporting the commercial deployment of Silex’s Quantum Silicon Production Plant. The intent of the Defence Trailblazer Program is to support the commercialisation of Australian technologies that will have a material benefit to the Defence sector in Australia. Through the Quantum Silicon Production Project, a sovereign end-to-end supply chain for critical quantum materials essential for silicon quantum computing will be created. The advent of quantum computing is expected to have profound impacts on Defence and National Security activities, and this Project is a perfect fit with the intent of the Trailblazer.” Professor Nicholas Fisk, Deputy Vice-Chancellor Research and Enterprise, UNSW Sydney, said: “UNSW Sydney is extremely pleased to support Silex and SQC in the Quantum Silicon Production Project under the Defence Trailblazer Program, in partnership with The University of Adelaide. As a major shareholder in SQC, and as the Administering Organisation for the Australian Research Council Centre of Excellence for Quantum Computation and Communication Technology, we have been impressed with the achievements in the previous CRC-P project for the development of ZS-Si production technology, and are excited to support the next step for commercial-scale production of Quantum Silicon. This Project is of critical importance to Australia’s ability to maintain leadership in an increasingly competitive and strategic endeavour to develop the world’s first scalable quantum computing technology.” Contributing to the ‘ Quantum Materials, Technologies and Computing Theme’ under the Defence Trailblazer Program, quantum computing capability is emerging as a vitally important strategic and national security technology, as evidenced by the global race to establish early mover advantage. The Trailblazer funding will support the commercialisation of Q-Si products for use in defence and civilian markets (domestic and offshore), while cementing areas of critical sovereign capability within Australia. Quantum technologies are expected to have a profound impact on our way of life in the decades to come, with quantum computing to open new frontiers and opportunities for defence and national security. The Q-Si Production Plant will include equipment for conversion of ZS-Si (in the form of halo-silane) into different product forms that are compatible with silicon quantum chip fabrication technologies utilised by manufacturers, namely: Quantum Silane gas – used in chemical vapour deposition (CVD) based processes utilised for quantum chip fabrication Quantum Silicon solid – used in atomic and molecular beam epitaxy (ABE / MBE) based processes utilised for quantum chip fabrication. A key benefit of the SILEX laser isotope separation technology is its modular nature, allowing the possibility for the production plant to be scaled up with additional modules, based on market demand and other factors. The 3.5-year Project has a total budget of ~$16m, of which $5.1m in funding will be provided by the Defence Trailblazer. Silex is currently resolving other avenues of financial support for the Project. Authorised for release by the Silex Board of Directors. Further information on the Company’s activities can be found on the Silex website: www.silex.com.au or by contacting investor.relations@silex.com.au. Forward Looking Statements and Risk Factors: About Silex Systems Limited (ASX: SLX) (OTCQX: SILXY) Silex Systems Limited ABN 69 003 372 067 ( Silex or the Company ) is a technology commercialisation company whose primary asset is the SILEX laser enrichment technology, originally developed at the Company’s technology facility in Sydney, Australia. The SILEX technology has been under development for uranium enrichment jointly with US-based exclusive licensee Global Laser Enrichment LLC (GLE) for a number of years. Success of the SILEX uranium enrichment technology development program and the proposed Paducah commercial project remain subject to a number of factors including the satisfactory completion of the engineering scale-up program and nuclear fuel market conditions and therefore remains subject to associated risks. Silex is also at various stages of development of additional commercial applications of the SILEX technology, including the production of ‘Zero-Spin Silicon’ for the emerging technology of silicon-based quantum computing. The ‘Quantum Silicon’ project remains dependent on the outcomes of the project and the viability of silicon quantum computing and is therefore subject to various risks. Silex is also conducting research activities in its Medical Isotope Separation Technology (MIST) Project, which is early-stage and subject to numerous risks. The commercial future of the SILEX technology in application to uranium, silicon, medical and other isotopes is therefore uncertain and any plans for commercial deployment are speculative. Additionally, Silex has an interest in a unique semiconductor technology known as ‘cREO ® ’ through its 100% ownership of subsidiary Translucent Inc. The cREO ® technology developed by Translucent has been acquired by IQE Plc based in the UK. IQE has paused the development of the cREO ® technology until a commercial opportunity arises. The future of IQE’s development program for cREO ® is very uncertain and remains subject to various technology and market risks. Forward Looking Statements The commercial potential of these technologies is currently unknown. Accordingly, no guarantees as to the future performance of these technologies can be made. The nature of the statements in this Announcement regarding the future of the SILEX technology as applied to uranium enrichment, Zero-Spin Silicon production, medical and other isotope separation projects, the cREO ® technology and any associated commercial prospects are forward-looking and are subject to a number of variables, including but not limited to, unknown risks, contingencies and assumptions which may be beyond the control of Silex, its directors and management. You should not place reliance on any forward-looking statements as actual results could be materially different from those expressed or implied by such forward-looking statements as a result of various risk factors. Further, the forward-looking statements contained in this Announcement involve subjective judgement and analysis and are subject to change due to management’s analysis of Silex’s business, changes in industry trends, government policies and any new or unforeseen circumstances. The Company’s management believes that there are reasonable grounds to make such statements as at the date of this Announcement Silex does not intend, and is not obligated, to update the forward-looking statements except to the extent required by law or the ASX Listing Rules. Risk Factors Risk factors that could affect future results and commercial prospects of Silex include, but are not limited to: ongoing economic and social uncertainty, including in relation to the impacts of the COVID-19 pandemic; geopolitical risks, in particular relating to Russia’s invasion of Ukraine and tensions between China and Taiwan which may impact global supply chains, among other risks; uncertainties related to the effects of climate change and mitigation efforts; the results of the GLE/SILEX uranium enrichment pilot demonstration program; the market demand for natural uranium and enriched uranium; the outcome of the project for the production of ‘Zero-Spin Silicon’ for the emerging technology of silicon-based quantum computing; the outcome of the MIST Project; the potential development of, or competition from alternative technologies; the potential for third party claims against the Company’s ownership of Intellectual Property; the potential impact of prevailing laws or government regulations or policies in the USA, Australia or elsewhere; whether IQE’s commercialisation program for cREO ® is resumed, the results from the program and the market opportunities for cREO ® products; actions taken by the Company’s commercialisation partners and other stakeholders that could adversely affect the technology development programs and commercialisation strategies; and the outcomes of various strategies and projects undertaken by the Company. Contact Details Silex Systems Limited Michael Goldsworthy | Julie Russell +61 2 9704 8888 investor.relations@silex.com.au Company Website https://www.silex.com.au/

August 17, 2023 09:00 AM Eastern Daylight Time

1 ... 222223224225226 ... 630